* immunocompromised individuals due to known or suspected immunodeficiency or due to receipt of immunosuppressive medication (e.g., steroids, biologics). * having had a severe adverse reaction (e.g., anaphylactic allergy) to mrna or pneumococcal vaccine. * having received pneumococcal polysaccharide vaccine within 12 months. * ltcf residents who have an interval less than 3 months from their third mrna covid vaccine dose.

* immunocompromised individuals due to known or suspected immunodeficiency or due to receipt of immunosuppressive medication (e.g., steroids, biologics). * having had a severe adverse reaction (e.g., anaphylactic allergy) to mrna or pneumococcal vaccine. * having received pneumococcal polysaccharide vaccine within 12 months. * ltcf residents who have an interval less than 3 months from their third mrna covid vaccine dose.

immunocompromised individuals due to known or suspected immunodeficiency or due to receipt of immunosuppressive medication (e.g., steroids, biologics). having had a severe adverse reaction (e.g., anaphylactic allergy) to mrna or pneumococcal vaccine. having received pneumococcal polysaccharide vaccine within 12 months. ltcf residents who have an interval less than 3 months from their third mrna covid vaccine dose.

immunocompromised individuals due to known or suspected immunodeficiency or due to receipt of immunosuppressive medication (e.g., steroids, biologics). having had a severe adverse reaction (e.g., anaphylactic allergy) to mrna or pneumococcal vaccine. having received pneumococcal polysaccharide vaccine within 12 months. ltcf residents who have an interval less than 3 months from their third mrna covid vaccine dose.

- immunocompromised individuals due to known or suspected immunodeficiency or due to receipt of immunosuppressive medication (e.g., steroids, biologics) - having had a severe adverse reaction (e.g., anaphylactic allergy) to mrna-1273 or pneumococcal prevnar-13 vaccine - having received pneumococcal polysaccharide vaccine within 12 months.

- immunocompromised individuals due to known or suspected immunodeficiency or due to receipt of immunosuppressive medication (e.g., steroids, biologics) - having had a severe adverse reaction (e.g., anaphylactic allergy) to mrna-1273 or pneumococcal prevnar-13 vaccine - having received pneumococcal polysaccharide vaccine within 12 months.

- immunocompromised individuals due to known or suspected immunodeficiency or due to receipt of immunosuppressive medication (e.g., steroids, biologics) - having had a severe adverse reaction (e.g., anaphylactic allergy) to mrna-1273

- immunocompromised individuals due to known or suspected immunodeficiency or due to receipt of immunosuppressive medication (e.g., steroids, biologics) - having had a severe adverse reaction (e.g., anaphylactic allergy) to mrna-1273